However, such compounds will also block innate immune surveillance [77,78] and, therefore, while such small molecule inhibitors have the potential to block CIN tumors from becoming metastatic [27], cGAS/STING inhibition might come at the price of local immune suppression and thus impaired tumor clearance. The gene discussed is CGAS; the disease is neoplasm.